Cargando…

Cost-Effectiveness Analysis of Sex-Stratified Plasmodium vivax Treatment Strategies Using Available G6PD Diagnostics to Accelerate Access to Radical Cure

Tafenoquine has been licensed for the single-dose radical cure of Plasmodium vivax in adults; however, it is only recommended in patients with > 70% of normal glucose-6-phosphate dehydrogenase (G6PD) activity. Because this may hinder widespread use, we investigated sex-based treatment strategies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Devine, Angela, Howes, Rosalind E., Price, David J., Moore, Kerryn A., Ley, Benedikt, Simpson, Julie A., Dittrich, Sabine, Price, Ric N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356471/ https://www.ncbi.nlm.nih.gov/pubmed/32372747 http://dx.doi.org/10.4269/ajtmh.19-0943

Ejemplares similares

Improving the Radical Cure of Plasmodium vivax Malaria
por: Price, Ric N.
Publicado: (2014)

A Review of the Current Status of G6PD Deficiency Testing to Guide Radical Cure Treatment for Vivax Malaria
por: Sadhewa, Arkasha, et al.
Publicado: (2023)

Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study
por: Devine, Angela, et al.
Publicado: (2021)

Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study
por: Rahmalia, Annisa, et al.
Publicado: (2023)

Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure
por: Thriemer, Kamala, et al.
Publicado: (2021)

Primaquine radical cure of Plasmodium vivax: a critical review of the literature
por: John, George K, et al.
Publicado: (2012)

Implementing radical cure diagnostics for malaria: user perspectives on G6PD testing in Bangladesh
por: Engel, Nora, et al.
Publicado: (2021)

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
por: Taylor, Walter R. J., et al.
Publicado: (2023)

Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group
por: Thriemer, Kamala, et al.
Publicado: (2017)

Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
por: Poespoprodjo, Jeanne Rini, et al.
Publicado: (2022)

Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
por: Taylor, Walter R J, et al.
Publicado: (2019)

Growing evidence of Plasmodium vivax across malaria-endemic Africa
por: Twohig, Katherine A., et al.
Publicado: (2019)

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis
por: Watson, James A, et al.
Publicado: (2022)

Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency
por: Commons, Robert J, et al.
Publicado: (2020)

Severe Hemolysis during Primaquine Radical Cure of Plasmodium vivax Malaria: Two Systematic Reviews and Individual Patient Data Descriptive Analyses
por: Yilma, Daniel, et al.
Publicado: (2023)

Diagnosis and Treatment of Plasmodium vivax Malaria
por: Baird, J. Kevin, et al.
Publicado: (2016)

Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis
por: Devine, Angela, et al.
Publicado: (2017)

A fluorometric assay to determine the protective effect of glucose-6-phosphate dehydrogenase (G6PD) against a Plasmodium spp. infection in females heterozygous for the G6PD gene: proof of concept in Plasmodium falciparum
por: Rumaseb, Angela, et al.
Publicado: (2022)

The challenges of introducing routine G6PD testing into radical cure: a workshop report
por: Ley, Benedikt, et al.
Publicado: (2015)

G6PD testing and radical cure for Plasmodium vivax in Cambodia: A mixed methods implementation study
por: Kheang, Soy Ty, et al.
Publicado: (2022)

The empirical support for the radical cure strategy for eliminating Plasmodium vivax in China
por: Yang, Guo-Jing, et al.
Publicado: (2022)

The anaemia of Plasmodium vivax malaria
por: Douglas, Nicholas M, et al.
Publicado: (2012)

How radical is radical cure? Site-specific biases in clinical trials underestimate the effect of radical cure on Plasmodium vivax hypnozoites
por: Huber, John H., et al.
Publicado: (2021)

Defining the relationship between Plasmodium vivax parasite rate and clinical disease
por: Battle, Katherine E, et al.
Publicado: (2015)

Plasmodium vivax in the Era of the Shrinking P. falciparum Map
por: Price, Ric N., et al.
Publicado: (2020)

Heterogeneity in prevalence of subclinical Plasmodium falciparum and Plasmodium vivax infections but no parasite genomic clustering in the Chittagong Hill Tracts, Bangladesh
por: Huwe, Tiffany, et al.
Publicado: (2022)

Active Pharmacovigilance for Primaquine Radical Cure of Plasmodium vivax Malaria in Odisha, India
por: Anvikar, Anupkumar R., et al.
Publicado: (2022)

Cost-Benefit Analysis of Tafenoquine for Radical Cure of Plasmodium vivax Malaria in Korea
por: Suh, Jiyeon, et al.
Publicado: (2022)

Comparison of three molecular methods for the detection and speciation of Plasmodium vivax and Plasmodium falciparum
por: Boonma, Prapaporn, et al.
Publicado: (2007)

Estimating the Proportion of Plasmodium vivax Recurrences Caused by Relapse: A Systematic Review and Meta-Analysis
por: Commons, Robert J., et al.
Publicado: (2020)

A systematic review of sub-microscopic Plasmodium vivax infection
por: Moreira, Clarissa M., et al.
Publicado: (2015)

Global Epidemiology of Plasmodium vivax
por: Howes, Rosalind E., et al.
Publicado: (2016)

The changing epidemiology of Plasmodium vivax: Insights from conventional and novel surveillance tools
por: Auburn, Sarah, et al.
Publicado: (2021)

Further evidence needed to change policy for the safe and effective radical cure of vivax malaria: Insights from the 2019 annual APMEN Vivax Working Group meeting
por: Ruwanpura, Varunika Sonani Hapuwatte, et al.
Publicado: (2021)

Plasmodium vivax morbidity after radical cure: A cohort study in Central Vietnam
por: Pham, Thanh Vinh, et al.
Publicado: (2019)

Safety and Efficacy of Tafenoquine for Plasmodium vivax Malaria Prophylaxis and Radical Cure: Overview and Perspectives
por: Markus, Miles B
Publicado: (2021)

Primaquine for Plasmodium vivax radical cure: What we do not know and why it matters
por: Popovici, Jean, et al.
Publicado: (2021)

Plasmodium vivax trophozoites insensitive to chloroquine
por: Sharrock, Wesley W, et al.
Publicado: (2008)

Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis
por: Commons, Robert J, et al.
Publicado: (2019)

Cost-effectiveness analysis of G6PD diagnostic test for Plasmodium vivax radical cure in Lao PDR: An economic modelling study
por: Aung, Yu Nandar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_efj3f6hmvaab54t9eh2tjmhm5u